688426 Jiangsu Cowin Biotech
- 19.68
- -0.10-0.51%
Jiangsu Cowin Biotech News
Summary announcement of the 2024 Restricted Stock Incentive Plan (draft).
Legal opinion of Tongli Law Firm, Shanghai regarding Jiangsu Kangwei Century Biotechnology Co., Ltd.'s 2024 restricted stock incentive plan (draft)
Supervisor Board's review opinion on the 2024 Restricted Stock Incentive Plan (Draft).
2024 Restricted Stock Incentive Plan (Draft)
List of incentive recipients granted restricted stock incentives plan in 2024.
Shareholder shareholding reduction plan announcement.
Announcement on the Progress of Stock Repurchase.
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement on the 2023 Profit Distribution Plan
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Announcement of the first exercise results and stock changes during the second exercise period of the 2021 Stock Options Incentive Plan
Announcement on the first repurchase of company shares through centralized bidding
Announcement on shareholding information of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Repurchase report on the repurchase of company shares through centralized bidding transactions
An indicative announcement regarding the actual controller, chairman and general manager of the company\'s proposal to repurchase the company\'s shares
Notice on the plan to repurchase the company\'s shares through centralized bidding
Notice on cancellation of some stock options already granted in the 2021 Stock Option Incentive Plan
Announcement on the fulfillment of the exercise conditions for the second exercise period of the 2021 Stock Options Incentive Plan
Legal opinion of Shanghai Tongli Law Firm on matters such as cancellation of options in the 2021 stock option incentive plan of Jiangsu Kangwei Century Biotechnology Co., Ltd., adjustment of exercise prices and number of options, and fulfillment of the lic
Announcement on adjusting the exercise price and number of options for the 2021 Stock Option Incentive Plan
Analysis
Price Target
No Data
